S.No Author Article Title Journal Title/Volume/ Issue/Pg/Year PMID File / Link
1 Petrs-Silva H, Dinculescu A, Li Q, Deng WT, Pang JJ, Min SH, Chiodo V, Neeley AW, Govindasamy L, Bennett A, Agbandje-McKenna M, Zhong L, Li B, Jayandharan GR, Srivastava A, Lewin AS, Hauswirth WW. Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina. Molecular Therapy, Volume:19/Issue:02, 293-301, February 2011. 21045809 Mol Ther. 2011 Feb;19(2) 293-301
2 Jayandharan GR, Aslanidi G, Martino AT, Jahn SC, Perrin GQ, Herzog RW, Srivastava A. Activation of the NF-kappaB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy. Proceedings of the National Academy of Sciences of the United States of America, Volume: 108/Issue:09, 3743-3748, March 2011. 21321191 Proc Natl Acad Sci U S A. 2011 Mar 1;108(9) 3743-8
3 Ma W, Li B, Ling C, Jayandharan GR, Srivastava A, Byrne BJ. A simple method to increase the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo. Human Gene Therapy, Volume:22/Issue:05, 633-640, May 2011. 21219084 Hum Gene Ther. 2011 May;22(5) 633-40
4 Liu J, Liao S, Huang Y, Samuel R, Shi T, Naxerova K, Huang P, Kamoun W, Jain RK, Fukumura D, Xu L. PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer. Clinical Cancer Research, Volume:17/Issue:11, 3638-3648, June 2011. 21459800 Clin Cancer Res. 2011 Jun 1;17(11) 3638-48
5 Rogers GL, Martino AT, Aslanidi GV, Jayandharan GR, Srivastava A, Herzog RW. Innate Immune Responses to AAV Vectors. Frontiers in Microbiology, Volume:02, 194, September 2011. 21954398 Front Microbiol. 2011 Sep 19;2, 194
6 Jayandharan GR, Srivastava A. Hemophilia: genetics, diagnosis and management. Genetic Syndromes & Gene Therapy, Volume: S1/Issue:005, 1-12, November 2011. - J Genet Syndr Gene Ther S1, 005, November 18, 2011